Hatzis-Schoch Brent bought BDTX
January 21, 2026 · Form 4 insider transaction
Hatzis-Schoch Brent bought 250,000 shares of Black Diamond Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
250,000
Price
$0.00
Total value
N/A
InsiderHatzis-Schoch Brent
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 21, 2026
Filing dateJanuary 23, 2026
Shares owned after250,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to this option shall vest and become exercisable on January 21, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.